ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q4SCImago #30,946Subscription

Drug Topics

Identifier (ISSN):0012-6616(Print)/1937-8157(Online)
•
Publisher:Advanstar Communications Inc.
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Drug Topics

WoS Q1
000002025
Annual Impact Factor Metric
Current (2025):0
Scopus SJR & RankScopus Q4
0.101
#30,946

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
8

8 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
0articles/year
0% Gold OA•0% Original Research

Aims & Scope

Drug Topics publishes only print or online content that is not commercial or promotional in nature and that has not been published elsewhere. In the interest of transparency, Drug Topics will, as necessary, ask authors and sources to provide disclosures or conflict-of-interest statements, which will be published as appropriate to further the cause of information service to the pharmacy community. There are several places in our magazine where your article may be used. One example is as a regular news story, such as coverage of a clinical meeting. Freelancers who are covering a meeting can contact the Editor first to see if we have any interest in obtaining coverage of the event.

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

1 year
2025Latest
IF0
Articles / Year—
Total Citations—

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #30,946Scopus Q4SCImago Profile
Scopus Coverage:1991, 1997-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q4
0.101

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4
Citations / Doc (2 years)
0.02

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,182 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5
3-Year Documents315
Citable Documents48

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate57.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ4
PharmacologyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Topics (ISSN: 0012-6616) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Advanstar Communications Inc. in United States. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.101 (Q4), an H-index of 8.

The journal enforces rigorous peer evaluation with an annual output of approximately 0 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,182 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Advanstar Communications Inc.
Publication Language
English
Frequency
Periodic
Indexing & Databases
ScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 882f95d5-80db-4be5-9e8c-28f0f909ff84
Database Updated: 2026-09-28